I have noticed that Ockerfan has not been posting for awhile. He will be missed. Always posted intelligently with lots of good facts. I think ( and I am going to get many thumbs down) that sometimes we longs think Kerx and Auryxia are one in the same. They are not. Just because A is a great drug does not mean Kerx is a great company. I am still here but I am watching this management team like a hawk
To me insider buying is as important as increasing scripts to get this stock price stabilized and moving up. The insider buying should put a floor under the price and then the scripts will move it on up! The ol one two punch.
No Kingfish not krapp. It appears to be a marketing strategy research study. Are we the target client being guided as to best marketing practices going forward or are we the competition that needs to be squelched? Either way it is valuable info imho.
Crazy! It has a 44 cent loss instead of a 50 cent loss and favorable mid stage trial. We have an approved drug, sales in Japan, CHMP and possible ckd expanded use and we are getting beat up. I am beginning to believe Wall Street hates this company.